Bio-Techne (TECH) Cash from Operations (2009 - 2026)
Bio-Techne's quarterly Cash from Operations came in at 86661000.0 in Q1 2026, up 110.75% year-on-year from 41120000.0 in Q1 2025, and up 5.16% quarter-over-quarter from 82411000.0 in Q4 2025.
Bio-Techne has reported Cash from Operations for 18 years, with the latest figure at 86661000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 110.75% year-over-year to 86661000.0; the trailing twelve-month figure through Mar 2026 stood at 294858000.0 (up 11.33% YoY), and the FY2025 full-year result was 287556000.0, down 3.82% from the prior year.
- Cash from Operations for Q1 2026 stood at 86661000.0, up from 82411000.0 in the prior quarter.
- The five-year high for Cash from Operations was 102717000.0 in Q2 2022, with the low at 27585000.0 in Q3 2025.
- Average Cash from Operations over 5 years is 71378352.94, with a median of 75496000.0 recorded in 2024.
- Year-over-year, Cash from Operations sank 56.82% in 2025 and jumped 110.75% in 2026.
- Tracing TECH's Cash from Operations over 5 years: stood at 64384000.0 in 2022, then gained by 29.09% to 83116000.0 in 2023, then rose by 1.48% to 84346000.0 in 2024, then slipped by 2.29% to 82411000.0 in 2025, then advanced by 5.16% to 86661000.0 in 2026.
- The last three Cash from Operations figures came in at 86661000.0 (Q1 2026), 82411000.0 (Q4 2025), and 27585000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 86.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.66 Mn |
| Mar 31, 2026 | 86.66 Mn |
| Dec 31, 2025 | 82.41 Mn |
| Dec 31, 2025 | 82.41 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Sep 30, 2025 | 27.59 Mn |
| Jun 30, 2025 | 98.20 Mn |
| Jun 30, 2025 | 98.20 Mn |
| Mar 31, 2025 | 41.12 Mn |
| Mar 31, 2025 | 41.12 Mn |
| Dec 31, 2024 | 84.35 Mn |
| Dec 31, 2024 | 84.35 Mn |
| Sep 30, 2024 | 63.89 Mn |
| Sep 30, 2024 | 63.89 Mn |
| Jun 30, 2024 | 75.50 Mn |
| Jun 30, 2024 | 75.50 Mn |
| Mar 31, 2024 | 80.99 Mn |
| Mar 31, 2024 | 80.99 Mn |
| Dec 31, 2023 | 83.12 Mn |
| Dec 31, 2023 | 83.12 Mn |
| Sep 30, 2023 | 59.38 Mn |
| Sep 30, 2023 | 59.38 Mn |
| Jun 30, 2023 | 83.39 Mn |
| Jun 30, 2023 | 83.39 Mn |
| Mar 31, 2023 | 50.54 Mn |
| Mar 31, 2023 | 50.54 Mn |
| Dec 31, 2022 | 64.38 Mn |
| Dec 31, 2022 | 64.38 Mn |
| Sep 30, 2022 | 56.08 Mn |
| Sep 30, 2022 | 56.08 Mn |
| Jun 30, 2022 | 102.72 Mn |
| Jun 30, 2022 | 102.72 Mn |
| Mar 31, 2022 | 73.13 Mn |
| Mar 31, 2022 | 73.13 Mn |
| Dec 31, 2021 | 100.99 Mn |
| Dec 31, 2021 | 100.99 Mn |
| Sep 30, 2021 | 48.43 Mn |
| Sep 30, 2021 | 48.43 Mn |
| Jun 30, 2021 | 122.02 Mn |
| Jun 30, 2021 | 122.02 Mn |
| Mar 31, 2021 | 74.87 Mn |
| Mar 31, 2021 | 74.87 Mn |
| Dec 31, 2020 | 89.27 Mn |
| Dec 31, 2020 | 89.27 Mn |
| Sep 30, 2020 | 66.01 Mn |
| Sep 30, 2020 | 66.01 Mn |
| Jun 30, 2020 | 44.79 Mn |
| Jun 30, 2020 | 44.79 Mn |
| Mar 31, 2020 | 49.47 Mn |
| Mar 31, 2020 | 49.47 Mn |
| Dec 31, 2019 | 70.42 Mn |
| Dec 31, 2019 | 70.42 Mn |
| Sep 30, 2019 | 40.54 Mn |
| Sep 30, 2019 | 40.54 Mn |
| Jun 30, 2019 | 55.95 Mn |
| Jun 30, 2019 | 55.95 Mn |
| Mar 31, 2019 | 39.66 Mn |
| Mar 31, 2019 | 39.66 Mn |
| Dec 31, 2018 | 46.56 Mn |
| Dec 31, 2018 | 46.56 Mn |
| Sep 30, 2018 | 39.45 Mn |
| Sep 30, 2018 | 39.45 Mn |
| Jun 30, 2018 | 64.84 Mn |
| Jun 30, 2018 | 64.84 Mn |
| Mar 31, 2018 | 21.65 Mn |
| Mar 31, 2018 | 21.65 Mn |
| Dec 31, 2017 | 39.18 Mn |
| Dec 31, 2017 | 39.18 Mn |
| Sep 30, 2017 | 44.70 Mn |
| Sep 30, 2017 | 44.70 Mn |
| Jun 30, 2017 | 50.85 Mn |
| Jun 30, 2017 | 50.85 Mn |
| Mar 31, 2017 | 25.02 Mn |
| Mar 31, 2017 | 25.02 Mn |
| Dec 31, 2016 | 41.63 Mn |
| Dec 31, 2016 | 41.63 Mn |
| Sep 30, 2016 | 26.50 Mn |
| Sep 30, 2016 | 26.50 Mn |
| Jun 30, 2016 | 36.65 Mn |
| Jun 30, 2016 | 36.65 Mn |
| Mar 31, 2016 | 37.14 Mn |
| Mar 31, 2016 | 37.14 Mn |
| Dec 31, 2015 | 38.54 Mn |
| Dec 31, 2015 | 38.54 Mn |
| Sep 30, 2015 | 31.83 Mn |
| Sep 30, 2015 | 31.83 Mn |
| Jun 30, 2015 | 37.14 Mn |
| Jun 30, 2015 | 37.14 Mn |
| Mar 31, 2015 | 30.78 Mn |
| Mar 31, 2015 | 30.78 Mn |
| Dec 31, 2014 | 35.73 Mn |
| Dec 31, 2014 | 35.73 Mn |
| Sep 30, 2014 | 35.72 Mn |
| Sep 30, 2014 | 35.72 Mn |
| Jun 30, 2014 | 37.92 Mn |
| Jun 30, 2014 | 37.92 Mn |
| Mar 31, 2014 | 34.93 Mn |
| Mar 31, 2014 | 34.93 Mn |
| Dec 31, 2013 | 31.32 Mn |
| Dec 31, 2013 | 31.32 Mn |
| Sep 30, 2013 | 32.59 Mn |
| Sep 30, 2013 | 32.59 Mn |
| Jun 30, 2013 | 29.99 Mn |
| Jun 30, 2013 | 29.99 Mn |
| Mar 31, 2013 | 33.03 Mn |
| Mar 31, 2013 | 33.03 Mn |
| Dec 31, 2012 | 31.29 Mn |
| Dec 31, 2012 | 31.29 Mn |
| Sep 30, 2012 | 29.26 Mn |
| Sep 30, 2012 | 29.26 Mn |
| Jun 30, 2012 | 37.41 Mn |
| Jun 30, 2012 | 37.41 Mn |
| Mar 31, 2012 | 34.46 Mn |
| Mar 31, 2012 | 34.46 Mn |
| Dec 31, 2011 | 20.44 Mn |
| Dec 31, 2011 | 20.44 Mn |
| Sep 30, 2011 | 34.43 Mn |
| Sep 30, 2011 | 34.43 Mn |
| Jun 30, 2011 | 34.67 Mn |
| Jun 30, 2011 | 34.67 Mn |
| Mar 31, 2011 | 32.39 Mn |
| Mar 31, 2011 | 32.39 Mn |
| Dec 31, 2010 | 29.43 Mn |
| Dec 31, 2010 | 29.43 Mn |
| Sep 30, 2010 | 30.70 Mn |
| Sep 30, 2010 | 30.70 Mn |
| Jun 30, 2010 | 31.78 Mn |
| Jun 30, 2010 | 31.78 Mn |
| Mar 31, 2010 | 23.22 Mn |
| Mar 31, 2010 | 23.22 Mn |
| Dec 31, 2009 | 28.23 Mn |
| Dec 31, 2009 | 28.23 Mn |
| Sep 30, 2009 | 28.03 Mn |
| Sep 30, 2009 | 28.03 Mn |